Location · Phoenix, AZ
Clinical trials in Phoenix, AZ
537 recruiting studies have a site in the Phoenix area, and 103 of them accept healthy volunteers. The area includes Scottsdale, Tempe, Mesa, Chandler, Gilbert, Glendale and nearby cities.
537 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
AbbVie
- Location
- Huntsville, AL + 32 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Anniston, AL + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of TAK-755 in Adults With Acute Ischemic Stroke
Takeda
- Location
- Scottsdale, AZ
- Eligibility basics
- Ages 18+
- Recruiting
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Reprise Biomedical, Inc.
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
GlaxoSmithKline
- Location
- Mobile, AL + 29 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2/Phase 3
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Chiesi Farmaceutici S.p.A.
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
X4 Pharmaceuticals
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Gilbert, AZ + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
- Location
- Phoenix, AZ + 11 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Scottsdale, AZ + 33 other US sites
- Eligibility basics
- Ages 45–75
- Recruiting
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Well Cell Global
- Location
- Phoenix, AZ + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
ATLAS (AltaValve) Pivotal Trial
4C Medical Technologies, Inc.
- Location
- Phoenix, AZ + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Chandler, AZ + 28 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2/Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Phoenix, AZ + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Artiva Biotherapeutics, Inc.
- Location
- Tuscaloosa, AL + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Terrestrial Bio, Inc.
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
- Location
- Huntsville, AL + 47 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingPhase 2
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
Novaliq GmbH
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Chandler, AZ + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Axsome Therapeutics, Inc.
- Location
- Auburn, AL + 37 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
PhenoNet, Inc.
- Location
- Scottsdale, AZ + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Navigator Medicines, Inc.
- Location
- Phoenix, AZ + 13 other US sites
- Eligibility basics
- Ages 18–70